(2-Methylpyridin-3-yl)methanamine dihydrochloride, 95.0%, 5g

(4-(5-Oxopyrazolidin-3-yl)phenyl)boronic acid, 97%, 100mg

tert-butyl 2,2,3,3,5,5,6,6-octadeuteriopiperazine-1-carboxylate, 97, 100mg

1,2,3,4,5-Pentamethylcyclopentadiene>93.0%(GC)5mL

(2S,3S)-4-(Anthracen-9-yl)-3-(tert-butyl)-2-isopropyl-2,3-dihydrobenzo[d][1,3]oxaphosphole, 97%, 100mg

p-Toluidine, 99.0%, 10g

N-([1,1'-Biphenyl]-4-yl)-N-(4-bromophenyl)-9,9-dimethyl-9H-fluoren-2-amine, 97%, 100g

Dodecamethylcyclohexasiloxane, 95%, 25g

3-(3-Bromophenyl)-1H-pyrazole-4-carbaldehyde, 250mg

Ethanol, 2-[2-[2-[2-(aminooxy)ethoxy]ethoxy]ethoxy]-, 95%, 1g

2-Methoxybutanohydrazidehydrochloride, 95.0%, 5g

(2R,3R,4R,5S)-5-(4-benzamido-2-oxopyrimidin-1(2H)-yl)-2-((benzoyloxy)methyl)-4-fluoro-4-methyltetrahydrofuran-3-yl benzoate, 98%, 250mg

5'-O-[Bis(4-methoxyphenyl)phenylmethyl]-adenosine, 97%, 250mg